DMK
CTIC

David M. Knott’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

David M. Knott’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$177K Hold
60,000
– – 0.06% 98
2021
Q2 		$150K Buy
60,000
+40,000
+200% +$95.9K 0.05% 107
2021
Q1 		$58K Hold
20,000
– – 0.02% 111
2020
Q4 		$64K Buy
+20,000
New +$66.5K 0.03% 88

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

David M. Knott's CTIC Position: Q3 2021 in Review

David M. Knott held its CTI BioPharma Corp. (DE) Common Stock (CTIC) position steady in Q3 2021 at 60,000 shares worth $177K. The position accounts for 0.06% of the portfolio, ranked #98.

David M. Knott first reported a position in CTIC in Q4 2020 and has held it in 4 quarters since. 56 funds tracked by Wall St. Rank hold CTIC as of Q3 2021.

  • David M. Knott held 60,000 shares of CTI BioPharma Corp. (DE) Common Stock worth $177K as of Q3 2021.
  • David M. Knott left its CTI BioPharma Corp. (DE) Common Stock share count unchanged in Q3 2021.
  • CTI BioPharma Corp. (DE) Common Stock made up 0.06% of David M. Knott's portfolio in Q3 2021, its #98 holding.
  • David M. Knott first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2020 and has held it in 4 quarters since.
  • 56 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.